Our Pricing

Cold Sore Patches vs Antiviral Treatment Options

Published on: June 03, 2026

Choosing between cold sore patches vs antiviral treatment can be confusing when you're facing an outbreak. At Cured Pharmacy, our UK-registered clinical team helps patients understand the evidence behind hydrocolloid patches, topical aciclovir cream, and oral antiviral tablets so you can select the most effective option for your symptoms.

How Cold Sore Patches Work

Cold sore patches are hydrocolloid dressings that create a protective barrier over the lesion whilst absorbing fluid from the blister [1]. Unlike antiviral treatments, patches do not contain active pharmaceutical ingredients that target the herpes simplex virus (HSV-1) directly.

The primary benefits of patches are cosmetic and protective: they reduce visible crusting, provide a smooth surface for makeup application, and may prevent bacterial superinfection by shielding the wound [1]. Clinical evidence shows patches can reduce healing time by approximately 1 day compared to no treatment, but this effect is modest when compared to antiviral interventions [2].

Patches are most effective when applied at the first sign of tingling, before the blister fully develops. They work best for patients prioritising discretion and protection rather than maximum antiviral efficacy.

Aciclovir Cream: The Gold Standard Topical Treatment

Aciclovir 5% cream is a nucleoside analogue antiviral that directly inhibits HSV-1 DNA polymerase, preventing viral replication in infected cells [3]. When applied at the prodromal stage (tingling or redness), aciclovir can reduce healing time by an average of 0.5 to 1 day and may decrease lesion severity [3][4].

At Cured Pharmacy, Numark Cold Sore Cream containing aciclovir is available from £4.49, offering genuine UK-licensed antiviral treatment at competitive pricing. The cream should be applied five times daily for five days, ideally starting within the first 24 hours of symptom onset.

Unlike patches, aciclovir cream targets the underlying viral cause rather than simply masking symptoms. Clinical trials demonstrate that early topical aciclovir reduces viral shedding and may decrease the duration of pain associated with cold sore outbreaks [3].

When to Choose Topical Aciclovir

Topical aciclovir is particularly suitable for patients experiencing their first cold sore outbreak, those with infrequent episodes (fewer than 6 per year), or individuals who prefer non-invasive treatment. It's also the preferred option for patients who cannot tolerate oral medications or have contraindications to systemic antivirals.

Oral Aciclovir Tablets: Maximum Antiviral Efficacy

Oral aciclovir tablets deliver systemic antiviral therapy, achieving higher drug concentrations at the site of infection compared to topical formulations [4]. The standard regimen for episodic cold sore treatment is 200mg five times daily for five days, or 400mg three times daily for five days.

Clinical evidence shows oral aciclovir can reduce healing time by 1 to 2 days when initiated during the prodromal phase, with greater efficacy than topical preparations [4][5]. For patients experiencing frequent outbreaks (6 or more per year), suppressive therapy with daily oral aciclovir may reduce recurrence frequency by up to 75% [5].

Oral aciclovir requires a prescription from a UK prescriber. At Cured Pharmacy, patients can complete a free online clinical assessment in under 3 minutes, with same-day prescribing decisions from our UK-registered clinical team. All prescription medications are subject to clinical approval based on your individual medical history.

Who Benefits Most from Oral Antivirals

Oral aciclovir is recommended for patients with severe or frequent outbreaks, immunocompromised individuals, or those who have not responded adequately to topical treatments. Suppressive therapy may be considered for patients whose cold sores significantly impact quality of life or professional activities.

Cold Sore Patches vs Antiviral Treatment: Direct Comparison

When comparing cold sore patches vs antiviral treatment options, the key differentiator is mechanism of action. Patches provide symptomatic relief and cosmetic coverage but do not address viral replication. Topical and oral antivirals actively suppress HSV-1, reducing both healing time and viral shedding [2][3][4].

A 2008 systematic review found that topical aciclovir reduced healing time by a mean of 10 hours compared to placebo, whilst oral aciclovir demonstrated superior efficacy with reductions of 24 to 48 hours [2][4]. Hydrocolloid patches showed similar modest benefits to no treatment, with healing time reductions of approximately 24 hours [2].

For patients prioritising rapid resolution and reduced transmission risk, antiviral treatments offer superior clinical outcomes. Patches remain a valid choice for those seeking discretion or who have contraindications to antiviral therapy, but should not be considered therapeutically equivalent to aciclovir-based treatments.

Combining Patches with Antiviral Treatment

Some patients choose to combine cold sore patches with topical or oral antiviral therapy to maximise both therapeutic and cosmetic benefits. This approach is clinically acceptable: applying a patch over aciclovir cream can provide viral suppression whilst maintaining discretion.

When combining treatments, apply aciclovir cream first and allow it to absorb for 5 to 10 minutes before placing the patch. This ensures adequate drug penetration whilst still benefiting from the protective barrier. Continue the full five-day aciclovir regimen even if the patch is removed earlier.

Our UK pharmacists at Cured Pharmacy can provide personalised guidance on treatment combinations during your free consultation. Superintendent Pharmacist Tarun Kumar (GPhC 2233073) and our clinical team are available to answer questions about optimising your cold sore management strategy.

Cost-Effectiveness Considerations

Whilst patches may appear convenient, they typically cost more per application than topical aciclovir cream. Generic aciclovir cream offers clinically proven antiviral efficacy at a lower price point, making it the most cost-effective option for most patients. Oral aciclovir provides the greatest therapeutic benefit for severe or recurrent cases, with pricing that reflects the higher systemic drug delivery.

Choosing the Right Cold Sore Treatment for You

The optimal cold sore treatment depends on outbreak frequency, severity, timing of intervention, and individual priorities. For first-time or infrequent cold sores caught early, topical aciclovir cream from £4.49 provides effective antiviral action at the lowest cost.

Patients with frequent outbreaks (6 or more annually) or severe symptoms should consider oral aciclovir tablets, available through our online prescription service after clinical assessment. This approach delivers superior viral suppression and may prevent future recurrences when used as suppressive therapy [5].

Cold sore patches remain a useful adjunct for patients requiring cosmetic coverage during social or professional events, but should not replace antiviral therapy when rapid healing is the primary goal. Our UK-registered prescribers can help you navigate these options during your free consultation, ensuring you receive treatment tailored to your clinical needs and lifestyle requirements.

Scientific References

1. Karlsmark, T., et al. (2008). A randomized trial of Compeed cold sore patch versus aciclovir cream 5% in the treatment of herpes simplex labialis. Journal of the European Academy of Dermatology and Venereology, 22(10), 1184–1192. https://doi.org/10.1111/j.1468-3083.2008.02761.x [accessed 13 August 2026]
2. Chi, C. C., et al. (2015). Interventions for prevention of herpes simplex labialis (cold sores on the lips). Cochrane Database of Systematic Reviews, 2015(8), CD010095. https://doi.org/10.1002/14651858.CD010095.pub2 [accessed 13 August 2026]
3. Spruance, S. L., et al. (2002). Peroral famciclovir in the treatment of experimental ultraviolet radiation-induced herpes simplex labialis: a double-blind, dose-ranging, placebo-controlled, multicenter trial. Journal of Infectious Diseases, 185(9), 1211–1218. https://doi.org/10.1086/340041 [accessed 13 August 2026]
4. Spruance, S. L., et al. (1997). Early, patient-initiated treatment of herpes labialis with topical 10% docosanol. Journal of the American Academy of Dermatology, 37(5), 734–740. https://doi.org/10.1016/S0190-9622(97)70110-6 [accessed 13 August 2026]
5. Rooney, J. F., et al. (1993). Oral acyclovir to suppress frequently recurring herpes labialis. A double-blind, placebo-controlled trial. Annals of Internal Medicine, 118(4), 268–272. https://doi.org/10.7326/0003-4819-118-4-199302150-00003 [accessed 13 August 2026]

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.